Literature DB >> 28339303

Development of RAP Tag, a Novel Tagging System for Protein Detection and Purification.

Yuki Fujii1, Mika K Kaneko1, Satoshi Ogasawara1, Shinji Yamada1, Miyuki Yanaka1, Takuro Nakamura1, Noriko Saidoh1, Kanae Yoshida1, Ryusuke Honma1, Yukinari Kato1,2.   

Abstract

Affinity tag systems, possessing high affinity and specificity, are useful for protein detection and purification. The most suitable tag for a particular purpose should be selected from many available affinity tag systems. In this study, we developed a novel affinity tag called the "RAP tag" system, which comprises a mouse antirat podoplanin monoclonal antibody (clone PMab-2) and the RAP tag (DMVNPGLEDRIE). This system is useful not only for protein detection in Western blotting, flow cytometry, and sandwich enzyme-linked immunosorbent assay, but also for protein purification.

Entities:  

Keywords:  RAP tag; affinity tag; monoclonal antibody; podoplanin; protein purification

Mesh:

Substances:

Year:  2017        PMID: 28339303      PMCID: PMC5404252          DOI: 10.1089/mab.2016.0052

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


Introduction

Affinity tag systems, which are useful for protein purification and detection, are classified into “peptide tags” and “protein tags.” Protein tags, including glutathione-S-transferase tag,( maltose-binding protein tag,( Fc tag of immunoglobulin,( and green fluorescent protein tag,( have numerous advantages because they are useful for protein expression in the soluble fraction or are easily detected using monoclonal antibodies (mAbs). In contrast, protein tags sometimes affect the character of the target proteins if they are large in size (>25 kDa); therefore, their removal is necessary before any protein analysis. Peptide tags are less likely to affect the structure and function of target proteins because of their small size (typically 1–2 kDa); therefore, it is not always necessary to remove the tag portion for protein analysis. The most appropriate peptide tag system can be selected from many available peptide tags, such as FLAG tag,( TARGET tag,( PA tag,( and MAP tag,( among many others.( These systems sometimes have disadvantages, such as low specificity, low affinity, or difficulty in achieving protein elution. Therefore, we need to develop further affinity tag systems to overcome these disadvantages of established affinity tag systems. We previously developed a mouse mAb (clone PMab-2) against the platelet aggregation-stimulating domain of rat podoplanin.( Podoplanin is a type I transmembrane protein, which is highly expressed in many normal cells and cancer cells, and is involved in tumor-induced platelet aggregation by binding to CLEC-2 on platelets.( Because PMab-2 possesses high affinity and specificity against rat podoplanin,( it was expected to be useful as an antitag antibody. Herein, we developed a novel affinity tag system, the “RAP tag” system, using PMab-2 mAb.

Results and Discussion

We first investigated the binding affinity between PMab-2 mAb and RAP tag (DMVNPGLEDRIE) using the BIAcore X100 system. Curve fitting showed the affinity for PMab-2–RAP tag interaction: k = 2.0 × 105 M−1 s−1, k = 2.0 × 10−3 s−1, and KD = 9.7 × 10−9 M, indicating that PMab-2 showed moderate affinity toward the RAP tag. Next, we examined whether the RAP tag system is useful for several protein detection systems. As depicted in Figure 1A, PMab-2 showed a strong single band corresponding to the molecular weight of human epidermal growth factor receptor (EGFR) with RAP tag (∼170 kDa) in Western blot analysis. Transfectants of EGFR were established previously.( PMab-2 did not show any nonspecific bands in CHO-K1 and LN229 cells, indicating that PMab-2 is very specific to the RAP tag. PMab-2 reacted with the EGFR with the N-terminal RAP tag, which was expressed in CHO-K1 cells in flow cytometry (Fig. 1B, left). As a positive control, antihuman EGFR mAbs (EMab-51 and AY13) recognized CHO-K1/EGFR (Fig. 1B, middle and right). We further investigated whether the RAP tag system is useful in sandwich enzyme-linked immunosorbent assay (ELISA). PMab-2 was immobilized, and the soluble ectodomain fragment of EGFR (EGFRec) with RAP tag was added at a concentration from 3 ng/mL to 10 μg/mL and detected by biotinylated NZ-1. As shown in Figure 1C, EGFRec was detected in a dose-dependent manner. These results indicate that the RAP tag system is useful for Western blotting, flow cytometry, and sandwich ELISA.

Detection and purification of RAP-tagged EGFR by the RAP tag system. (A) Western blot analysis of RAP-tagged EGFR using anti-RAP tag mAb, PMab-2. Total cell lysates (CHO-K1, CHO/EGFR, LN229, and LN229/EGFR) were electrophoresed under reducing conditions using 5%–20% SDS-PAGE gel and transferred to a membrane. The membrane containing the same amount of lysate was immunoblotted using 1 μg/mL PMab-2 (anti-RAP tag), AC-15 (anti-β-actin), or RMab-3 (anti-IDH1) for 30 minutes, and incubated with a peroxidase-conjugated secondary antibody specific for mouse IgG. (B) Flow cytometric analysis of RAP-tagged membrane protein. Two antihuman EGFR mAbs (clones: EMab-51 and AY13) were used in this study. EMab-51 (IgG1, κ) was established in our laboratory. AY13 (IgG1, κ) was purchased from BioLegend (San Diego, CA). CHO-K1 cells and CHO/RAP-EGFR were treated with 1 μg/mL PMab-2, EMab-51, or AY13 for 30 minutes at 4°C, followed by 1:1000 diluted Oregon Green 488 goat antimouse IgG (Thermo Fisher Scientific, Inc., Waltham, MA). Fluorescence data were collected using a Cell Analyzer EC800 (Sony Corp., Tokyo, Japan). (C) Sandwich ELISA of RAP-tagged protein. PMab-2 was immobilized at a concentration of 10 μg/mL for 30 minutes. After blocking with 1% bovine serum albumin in 0.05% Tween 20/phosphate-buffered saline (pH 7.4), recombinant PA-EGFRec-RAP-MAP was added at a concentration from 3 ng/mL to 10 μg/mL and was incubated overnight. After washing, the plates were incubated with 0.5 μg/mL biotinylated NZ-1 (anti-PA tag), followed by 1:5000 diluted peroxidase-conjugated streptavidin (GE Healthcare Bio-Sciences, Pittsburgh, PA). The enzymatic reaction was performed using 1-Step Ultra TMB-ELISA (Thermo Fisher Scientific, Inc.). The optical density was measured at 655 nm using an iMark microplate reader (Bio-Rad Laboratories, Inc., Berkeley, CA). Data are means of four replicates ± SEM. (D) Purification of soluble ectodomain fragment of EGFR (EGFRec). LN229/EGFRec was cultured and 1 L of culture supernatant was harvested. The filtered supernatant was passed through PMab-2-Sepharose (4 mL bed volume), and the same process was repeated three times. The beads were then washed with 80 mL of Tris-buffered saline (TBS; pH 7.5) and eluted with 0.1 mg/mL epitope peptide in a step-wise manner (4 mL × 10). Ten microliters of the 5th of 5 washes in TBS (wash) and 10 peptide-eluted fractions (lanes 1–10) during the column chromatography were subjected to 5%–20% SDS-PAGE under reducing conditions and were stained with Coomassie brilliant blue. Arrow: EGFRec. ec, ectodomain; EGFR, epidermal growth factor receptor; ELISA, enzyme-linked immunosorbent assay; mAb, monoclonal antibody; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; SS, signal sequence.

Detection and purification of RAP-tagged EGFR by the RAP tag system. (A) Western blot analysis of RAP-tagged EGFR using anti-RAP tag mAb, PMab-2. Total cell lysates (CHO-K1, CHO/EGFR, LN229, and LN229/EGFR) were electrophoresed under reducing conditions using 5%–20% SDS-PAGE gel and transferred to a membrane. The membrane containing the same amount of lysate was immunoblotted using 1 μg/mL PMab-2 (anti-RAP tag), AC-15 (anti-β-actin), or RMab-3 (anti-IDH1) for 30 minutes, and incubated with a peroxidase-conjugated secondary antibody specific for mouse IgG. (B) Flow cytometric analysis of RAP-tagged membrane protein. Two antihuman EGFR mAbs (clones: EMab-51 and AY13) were used in this study. EMab-51 (IgG1, κ) was established in our laboratory. AY13 (IgG1, κ) was purchased from BioLegend (San Diego, CA). CHO-K1 cells and CHO/RAP-EGFR were treated with 1 μg/mL PMab-2, EMab-51, or AY13 for 30 minutes at 4°C, followed by 1:1000 diluted Oregon Green 488 goat antimouse IgG (Thermo Fisher Scientific, Inc., Waltham, MA). Fluorescence data were collected using a Cell Analyzer EC800 (Sony Corp., Tokyo, Japan). (C) Sandwich ELISA of RAP-tagged protein. PMab-2 was immobilized at a concentration of 10 μg/mL for 30 minutes. After blocking with 1% bovine serum albumin in 0.05% Tween 20/phosphate-buffered saline (pH 7.4), recombinant PA-EGFRec-RAP-MAP was added at a concentration from 3 ng/mL to 10 μg/mL and was incubated overnight. After washing, the plates were incubated with 0.5 μg/mL biotinylated NZ-1 (anti-PA tag), followed by 1:5000 diluted peroxidase-conjugated streptavidin (GE Healthcare Bio-Sciences, Pittsburgh, PA). The enzymatic reaction was performed using 1-Step Ultra TMB-ELISA (Thermo Fisher Scientific, Inc.). The optical density was measured at 655 nm using an iMark microplate reader (Bio-Rad Laboratories, Inc., Berkeley, CA). Data are means of four replicates ± SEM. (D) Purification of soluble ectodomain fragment of EGFR (EGFRec). LN229/EGFRec was cultured and 1 L of culture supernatant was harvested. The filtered supernatant was passed through PMab-2-Sepharose (4 mL bed volume), and the same process was repeated three times. The beads were then washed with 80 mL of Tris-buffered saline (TBS; pH 7.5) and eluted with 0.1 mg/mL epitope peptide in a step-wise manner (4 mL × 10). Ten microliters of the 5th of 5 washes in TBS (wash) and 10 peptide-eluted fractions (lanes 1–10) during the column chromatography were subjected to 5%–20% SDS-PAGE under reducing conditions and were stained with Coomassie brilliant blue. Arrow: EGFRec. ec, ectodomain; EGFR, epidermal growth factor receptor; ELISA, enzyme-linked immunosorbent assay; mAb, monoclonal antibody; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; SS, signal sequence. Next, we purified three different RAP-tagged proteins using the RAP tag system. The EGFRec and the soluble ectodomain fragment of human epidermal growth factor receptor 2 (HER2ec) were expressed in LN229 and were purified from the culture supernatant (Fig. 1D and Supplementary Fig. S1A). The fragment of α-thalassemia/mental-retardation-syndrome-X-linked (ATRXepi; ∼25 kDa) was expressed in Escherichia coli and purified from the soluble fraction of the bacterial lysate (Supplementary Fig. S1B). All RAP-tagged proteins were captured onto PMab-2-Sepharose and eluted from the resin by a solution containing 0.1 mg/mL free epitope peptide (GDDMVNPGLEDRIE). These proteins were efficiently eluted using the RAP tag peptide because of the high dissociation constant for PMab-2–RAP tag interaction. EGFRec and HER2ec were eluted in elution fractions 2–4 (EGFRec) or 2–3 (HER2ec) at a high concentration (Fig. 1D and Supplementary Fig. S1A). EGFRec and HER2ec are highly glycosylated(; therefore, they were electrophoresed at a “heavier” position compared with that suggested by the theoretical molecular weight. ATRXepi was eluted in elution fractions 2–10 (Supplementary Fig. S1B). These purified proteins showed high purity and were ready for use in downstream experiments without further purification, indicating that the RAP tag system is a powerful protein purification tool. In conclusion, we successfully developed a novel affinity tagging system, “RAP tag,” by employing a unique mAb PMab-2 against rat podoplanin. The RAP tag system could be advantageous for protein purification and detection in the field of protein science.
  33 in total

1.  Tailored placement of a turn-forming PA tag into the structured domain of a protein to probe its conformational state.

Authors:  Yuki Fujii; Yukiko Matsunaga; Takao Arimori; Yu Kitago; Satoshi Ogasawara; Mika K Kaneko; Yukinari Kato; Junichi Takagi
Journal:  J Cell Sci       Date:  2016-02-12       Impact factor: 5.285

2.  Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

Authors:  Yukinari Kato; Ganesan Vaidyanathan; Mika Kato Kaneko; Kazuhiko Mishima; Nidhi Srivastava; Vidyalakshmi Chandramohan; Charles Pegram; Stephen T Keir; Chien-Tsun Kuan; Darell D Bigner; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2010-10       Impact factor: 2.408

3.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

4.  Novel Monoclonal Antibody LpMab-17 Developed by CasMab Technology Distinguishes Human Podoplanin from Monkey Podoplanin.

Authors:  Yukinari Kato; Satoshi Ogasawara; Hiroharu Oki; Ryusuke Honma; Michiaki Takagi; Yuki Fujii; Takuro Nakamura; Noriko Saidoh; Hazuki Kanno; Mitsuo Umetsu; Satoshi Kamata; Hiroshi Kubo; Mitsuhiro Yamada; Yoshihiko Sawa; Kei-Ichi Morita; Hiroyuki Harada; Hiroyoshi Suzuki; Mika Kato Kaneko
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2016-03-03

5.  PMab-44 Detects Bovine Podoplanin in Immunohistochemistry.

Authors:  Ryusuke Honma; Satoshi Ogasawara; Mika K Kaneko; Yuki Fujii; Hiroharu Oki; Takuro Nakamura; Michiaki Takagi; Satoru Konnai; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2016-06-07

6.  Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method.

Authors:  J Field; J Nikawa; D Broek; B MacDonald; L Rodgers; I A Wilson; R A Lerner; M Wigler
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

7.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

8.  MAP Tag: A Novel Tagging System for Protein Purification and Detection.

Authors:  Yuki Fujii; Mika K Kaneko; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2016-11-01

9.  Multi-specific monoclonal antibody MsMab-2 recognizes IDH1-R132L and IDH2-R172M mutations.

Authors:  Satoshi Ogasawara; Mika Kato Kaneko; Yuta Tsujimoto; Xing Liu; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-12

10.  LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin.

Authors:  Yukinari Kato; Satoshi Ogasawara; Hiroharu Oki; Polina Goichberg; Ryusuke Honma; Yuki Fujii; Mika K Kaneko
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

View more
  13 in total

1.  Anti‑EGFR monoclonal antibody 134‑mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.

Authors:  Hideki Hosono; Junko Takei; Tomokazu Ohishi; Masato Sano; Teizo Asano; Yusuke Sayama; Takuro Nakamura; Miyuki Yanaka; Manabu Kawada; Hiroyuki Harada; Mika Kato Kaneko; Yukinari Kato
Journal:  Int J Mol Med       Date:  2020-08-10       Impact factor: 4.101

2.  The mouse-canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models.

Authors:  Yukinari Kato; Tomokazu Ohishi; Manabu Kawada; Naoya Maekawa; Satoru Konnai; Shunsuke Itai; Shinji Yamada; Mika K Kaneko
Journal:  Biochem Biophys Rep       Date:  2018-11-24

3.  Establishment of EMab-134, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Detecting Squamous Cell Carcinoma Cells of the Oral Cavity.

Authors:  Shunsuke Itai; Shinji Yamada; Mika K Kaneko; Yao-Wen Chang; Hiroyuki Harada; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2017-11-01

4.  H2Mab-77 is a Sensitive and Specific Anti-HER2 Monoclonal Antibody Against Breast Cancer.

Authors:  Shunsuke Itai; Yuki Fujii; Mika K Kaneko; Shinji Yamada; Takuro Nakamura; Miyuki Yanaka; Noriko Saidoh; Yao-Wen Chang; Saori Handa; Maki Takahashi; Hiroyoshi Suzuki; Hiroyuki Harada; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2017-07-12

5.  The PHD finger of Arabidopsis SIZ1 recognizes trimethylated histone H3K4 mediating SIZ1 function and abiotic stress response.

Authors:  Kenji Miura; Na Renhu; Takuya Suzaki
Journal:  Commun Biol       Date:  2020-01-10

6.  Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L1Mab-4.

Authors:  Shinji Yamada; Shunsuke Itai; Mika K Kaneko; Yukinari Kato
Journal:  Biochem Biophys Rep       Date:  2018-02-06

7.  Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin.

Authors:  Yukinari Kato; Takuya Mizuno; Shinji Yamada; Takuro Nakamura; Shunsuke Itai; Miyuki Yanaka; Masato Sano; Mika K Kaneko
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2018-11

8.  In-plate recapturing of a dual-tagged recombinant Fasciola antigen (FhLAP) by a monoclonal antibody (US9) prevents non-specific binding in ELISA.

Authors:  Ricardo A Orbegozo-Medina; Victoria Martínez-Sernández; María J Perteguer; Ana Hernández-González; Mercedes Mezo; Marta González-Warleta; Fernanda Romarís; Esperanza Paniagua; Teresa Gárate; Florencio M Ubeira
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

9.  Development of EMab-51, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in Flow Cytometry, Western Blot, and Immunohistochemistry.

Authors:  Shunsuke Itai; Mika K Kaneko; Yuki Fujii; Shinji Yamada; Takuro Nakamura; Miyuki Yanaka; Noriko Saidoh; Saori Handa; Yao-Wen Chang; Hiroyoshi Suzuki; Hiroyuki Harada; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2017-09-11

10.  Antibody-Drug Conjugates Using Mouse-Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model.

Authors:  Yukinari Kato; Yuji Ito; Tomokazu Ohishi; Manabu Kawada; Takuro Nakamura; Yusuke Sayama; Masato Sano; Teizo Asano; Miyuki Yanaka; Saki Okamoto; Saori Handa; Yu Komatsu; Junko Takei; Mika K Kaneko
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2020-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.